Nereid Therapeutics will advance research by Clifford Brangwynne of Princeton University following its launch with a $50m series A round from Apple Tree Partners.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

WuXi AppTec’s Corporate Venture Fund was among the participants in a series A round disclosed as the precision medicine startup emerged from stealth.

The medical social network operator will target chronic disease management startups through the $76.3m fund, formed with Wuhan S&T Investment and China Merchants Bank.

Omron and Qualcomm Ventures returned to help AliveCor close a series E round that will fund the bolstering of its advanced ECG system.

The $11.5m Echo Health Ventures-backed round more than doubled the healthcare navigation app developer's overall funding.

MTG Ventures and Ohara Pharmaceutical backed the second close of the medical data modelling technology developer’s latest round, which stands at $12.4m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Chronic illness drug developer Sigilon Therapeutics, co-founded by MIT and UIC researchers, has filed to go public after raising almost $200m in funding.

Chronic illness drug developer Sigilon Therapeutics has filed to go public after raising almost $200m from investors including Eli Lilly.